Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.79 |
| ▸ | GABRD | O14764 | 2/20 | 0.79 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.79 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.79 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.79 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.79 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.79 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.79 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.79 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.79 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.79 |
| ▸ | GABRE | P78334 | 2/20 | 0.79 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.79 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.79 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.79 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.79 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30310279 | 1.00 | GABRP (0.79) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL11850706 | 0.90 | GABRP (0.75) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL10805397 | 0.88 | GABRP (0.77) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL5023108 | 0.88 | GABRP (1.00) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Bromide SCHEMBL11306196 | 0.87 | GABRP (0.97) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL11037113 | 0.86 | GABRP (0.73) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL18076411 | 0.85 | GABRP (0.72) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31541264 | 0.84 | GABRP (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Oxazafone SCHEMBL2108261 | 0.83 | GABRP (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Oxazafone SCHEMBL30090496 | 0.83 | GABRP (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | claimed |
| CN-106397242-A | Method for producing 2-(N-methyl chloride acetamido)-5-chlorobenzophenone | 枣阳凤泽精细化工有限公司 | 2017-02-15 | — | — | CN | claimed |
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | disclosed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | disclosed |
| US-20220162173-A1 | COMPOSITIONS AND METHODS FOR REDUCING TACTILE DYSFUNCTION, ANXIETY, AND SOCIAL IMPAIRMENT | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-05-26 | — | — | US | disclosed |
| CN-106397242-A | Method for producing 2-(N-methyl chloride acetamido)-5-chlorobenzophenone | 枣阳凤泽精细化工有限公司 | 2017-02-15 | — | — | CN | disclosed |
| US-4049666-A | THE 2-(N-(HALOALKYL OR HALOACYL)-N-(ACYLOXYALKYL OR CARBOBENZOXYALKYL)AMINOPHENYL) PYRIDYL KETONE INTERMEDIATES | HOFFMAN-LA ROCHE INC. (US) | 1977-09-20 | — | — | US | disclosed |
| US-4049667-A | THE 2-(N-(HALO-CARBALKOXY-ALKYL OR ACYL)-N-(ACYLOXYALKYL OR CARBOBENZOXYALKYL)AMINOPHENYL) PYRIDYL KETONE INTERMEDIATES | HOFFMANN-LA ROCHE INC. (US) | 1977-09-20 | — | — | US | disclosed |
| US-4017532-A | SEDATIVES, MUSCLE RELAXANTS, ANTICONVULSANTS | HOFFMANN-LA ROCHE INC. (US) | 1977-04-12 | — | — | US | disclosed |
| US-4017531-A | SEDATIVE, MUSCLE RELAXANT, ANTICONVULSANT | HOFFMANN-LA ROCHE INC. (US) | 1977-04-12 | — | — | US | disclosed |
| US-4014916-A | SEDATIVES, MUSCLE RELAXANTS AND ANTICONVULSANT AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1977-03-29 | — | — | US | disclosed |
| US-3997591-A | SEDATIVES, MUSCLE RELAXANT, ANTICONVULSANT | HOFFMANN-LA ROCHE INC. (US) | 1976-12-14 | — | — | US | disclosed |
| US-3996209-A | Process for preparing benzodiazepines | HOFFMANN-LA ROCHE INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3965151-A | 2-(AMINO OR AMIDO)-BENZOPHENONES | HOFFMANN-LA ROCHE INC. (US) | 1976-06-22 | — | — | US | disclosed |
| US-3950383-A | SEDATIVES, MUSCLE RELAXANTS, ANTIAGGRESSION | CASSELLA FARBWERKE MAINKUR AKT (DT) | 1976-04-13 | — | — | US | disclosed |
| US-3931314-A | CNS SEDATIVES, MUSCLE RELAXANTS, ANTIAGGRESSION | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
| US-3931301-A | SEDATIVE, ANTIAGGRESSION, MUSCLE RELAXANT | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162173-A1 | COMPOSITIONS AND METHODS FOR REDUCING TACTILE DYSFUNCTION, ANXIETY, AND SOCIAL IMPAIRMENT | GABBR1, GABBR2, PMP22 | GABRP 17/4885GABRD 14/4885GABRA1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.